DataMeds AI co-CEO Gerald Commissiong buys 5,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
DataMeds AI, Inc. (MEDS) reported that Co-Chief Executive Officer Gerald Commissiong purchased 5,000 shares at $1.09 per share on November 20, 2026. The purchase was made on the Nasdaq Capital Market.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Shares purchased: 5,000 shares
Purchase price: $1.09 per share
2 metrics
Shares purchased
5,000 shares
Gerald Commissiong's purchase on November 20, 2026
Purchase price
$1.09 per share
Gerald Commissiong's purchase on November 20, 2026
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.